Bloomberg News

Medical Compression Gets FDA Warning on Production Process

October 27, 2011

Oct. 27 (Bloomberg) -- Medical Compression Systems (DBN) Ltd. said a warning letter it received from the U.S. Food and Drug Administration covers all of the company’s products and doesn’t relate to safety or efficacy, according to a statement filed today with Tel Aviv Stock Exchange.

The letter covers the production process, labeling and quality checking, according to a statement filed yesterday

To contact the reporter on this story: Susan Lerner in Jerusalem at slerner2@bloomberg.net

To contact the editor responsible for this story: Louis Meixler at lmeixler@bloomberg.net


Monsanto vs. GMO Haters
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus